Listen: Inside the vaccine race, how a Covid pill failed, & Biogen’s troubled launch

Is Moderna misunderstood? Can Biogen turn a profit in Alzheimer’s disease? And what went wrong with the latest Covid-19 pill?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Wall Street Journal reporter Gregory Zuckerman joins us to share some behind-the-scenes details from race to develop a Covid-19 vaccine, the subject of his new book. We also discuss the latest news in the life sciences, including Biogen’s failure to launch, the plight of a Covid pill, and a headline-grabbing statement from one of biotech’s most famous scientists.

For more on what we cover, here’s where you can pre-order Zuckerman’s book; here’s the news from Atea Pharmaceuticals; here’s the latest on Biogen; here’s more from the HLTH conference; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the Covid-19 pandemic.

Be sure to sign up on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].